Thorne Enters into Definitive Agreement to Be Acquired by Procter & Gamble
Rhea-AI Summary
Procter & Gamble (NYSE: PG) has entered into a definitive agreement to acquire Thorne, a provider of science-backed health and wellness solutions. According to Thorne, the deal is intended to support its mission of becoming a leading personalized health brand while maintaining its focus on science, quality, and trust.
P&G states that acquiring Thorne is an important step for its Personal Health Care business, enhancing its position in premium wellness and personalized health. The transaction is expected to close later in 2026, subject to customary closing conditions and regulatory approvals, with P&G acquiring Thorne from L Catterton's Flagship Fund.
Positive
- Definitive acquisition agreement between P&G and Thorne announced
- Deal expected to enhance P&G Personal Health Care's premium wellness offering
- Acquisition aims to support Thorne's personalized health growth strategy
- P&G to acquire Thorne from L Catterton's Flagship Fund, providing ownership transition clarity
Negative
- Transaction closing is subject to customary conditions and regulatory approvals, creating completion uncertainty
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Jul 22 | Product launch | Positive | +0.7% | Swiffer introduced a lemon-scented duster line with dust-trapping technology. |
| Jul 16 | Brand partnership | Positive | +2.3% | Head & Shoulders debuted a multi-year USA Gymnastics partnership. |
| Jul 14 | Dividend declaration | Positive | +1.4% | PG declared a quarterly dividend of $1.0885 per share. |
| Jul 06 | Marketing campaign | Positive | -1.4% | Febreze launched a nationwide campaign with Major League Soccer. |
| Jul 01 | Earnings webcast | Positive | +0.5% | PG scheduled a webcast discussing fourth-quarter fiscal 2026 results. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
PG's recent company-news reactions were generally positive, with one product-campaign announcement followed by a negative move.
Key Terms
definitive agreement regulatory
regulatory approvals regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.
Acquisition positions Thorne to continue advancing its mission while building on its legacy of science, quality, innovation, and trust
Since 1984, Thorne has been a trusted partner to healthcare practitioners and a leader in science-backed health solutions, serving consumers, athletes, and healthcare professionals through rigorous science, world-class manufacturing, and uncompromising quality. Together, Thorne and P&G share a belief that trusted brands are built through a relentless commitment to quality, innovation, and earning consumer trust.
The acquisition positions Thorne to continue advancing its mission to become the world's most trusted personalized health brand by helping consumers live healthier lives through science-backed solutions they can trust.
"For more than 40 years, Thorne has earned the trust of healthcare practitioners, consumers, and partners by putting science, quality, and the people we serve at the center of every decision," said Colin Watts, Chief Executive Officer of Thorne. "As we looked to the future, we kept coming back to one question: What will best position Thorne to continue fulfilling its mission? We believe P&G is the right partner to help us expand our impact while staying true to the values and standards that have always defined Thorne."
"This is an important step for P&G's Personal Health Care business," said Paul Gama, CEO P&G Health Care. "Consumer interest in self-care, prevention, wellness, and personalized health continues to grow, and Thorne strengthens our position in premium wellness with a trusted, science-backed brand that complements our existing portfolio."
The transaction is expected to close later this year, subject to customary closing conditions and regulatory approvals. P&G will acquire Thorne from L Catterton's Flagship Fund. Perella Weinberg served as the lead financial advisor to Thorne.
About Thorne®:
Thorne is the leader in science-backed health and wellness solutions built to connect the science of performance with the science of people. As the top recommended clinical brand by health-care practitioners, Thorne offers a comprehensive range of nutritional supplements and innovative technology tools including Taia™ – Thorne's AI-powered wellness advisor – empowering individuals to take control of their health and wellness journey with confidence. Founded in 1984, Thorne develops products with high-quality ingredients, guided by clinical research and an in-house team of doctors, researchers, and scientists to ensure every formula meets rigorous standards for purity, potency, and efficacy. Thorne maintains a vertically integrated model, setting the industry standard for supplement manufacturing at its own facility in
ABOUT PROCTER & GAMBLE
P&G serves consumers around the world with one of the strongest portfolios of trusted, quality, leadership brands, including Always®, Ambi Pur®, Ariel®, Bounty®, Charmin®, Crest®, Dawn®, Downy®, Fairy®, Febreze®, Gain®, Gillette®, Head & Shoulders®, Lenor®, Olay®, Oral-B®, Pampers®, Pantene®, SK-II®, Tide®, Vicks®, and Whisper®. The P&G community includes operations in approximately 70 countries worldwide. Please visit https://www.pg.com for the latest news and information about P&G and its brands. For other P&G news, visit us at https://www.pg.com/news.
View original content to download multimedia:https://www.prnewswire.com/news-releases/thorne-enters-into-definitive-agreement-to-be-acquired-by-procter--gamble-302842751.html
SOURCE Thorne